A detailed history of Huntington National Bank transactions in Exact Sciences Corp stock. As of the latest transaction made, Huntington National Bank holds 394 shares of EXAS stock, worth $22,647. This represents 0.0% of its overall portfolio holdings.

Number of Shares
394
Previous 42 838.1%
Holding current value
$22,647
Previous $1,000 2500.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$42.43 - $70.83 $14,935 - $24,932
352 Added 838.1%
394 $26,000
Q2 2024

Aug 08, 2024

SELL
$41.33 - $74.26 $1,198 - $2,153
-29 Reduced 40.85%
42 $1,000
Q1 2024

May 03, 2024

SELL
$56.27 - $73.77 $281 - $368
-5 Reduced 6.58%
71 $4,000
Q4 2023

Feb 07, 2024

SELL
$59.06 - $75.72 $1,535 - $1,968
-26 Reduced 25.49%
76 $5,000
Q3 2023

Nov 08, 2023

BUY
$65.94 - $99.04 $329 - $495
5 Added 5.15%
102 $6,000
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $2,883 - $4,372
46 Added 90.2%
97 $9,000
Q1 2023

May 10, 2023

BUY
$47.19 - $70.77 $2,406 - $3,609
51 New
51 $3,000
Q4 2021

Jan 21, 2022

SELL
$72.5 - $100.68 $1,232 - $1,711
-17 Reduced 11.97%
125 $10,000
Q4 2020

Jan 11, 2021

BUY
$99.61 - $142.12 $14,144 - $20,181
142 New
142 $19,000
Q3 2020

Oct 30, 2020

SELL
$72.92 - $102.01 $947 - $1,326
-13 Closed
0 $0
Q2 2020

Jul 30, 2020

BUY
$55.75 - $92.75 $724 - $1,205
13 New
13 $1,000
Q1 2020

Apr 27, 2020

SELL
$37.9 - $104.44 $8,717 - $24,021
-230 Closed
0 $0
Q4 2019

Jan 17, 2020

BUY
$77.66 - $99.74 $17,861 - $22,940
230 New
230 $21,000
Q1 2019

Apr 09, 2019

SELL
$61.98 - $96.5 $805 - $1,254
-13 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$48.29 - $80.6 $627 - $1,047
13 New
13 $1,000
Q1 2018

Apr 30, 2018

SELL
$39.82 - $57.53 $40,735 - $58,853
-1,023 Closed
0 $0
Q3 2017

Oct 24, 2017

BUY
$37.05 - $47.12 $37,902 - $48,203
1,023
1,023 $48,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.